BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

955 related articles for article (PubMed ID: 28602971)

  • 1. New Developments in Hepatorenal Syndrome.
    Mindikoglu AL; Pappas SC
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):162-177.e1. PubMed ID: 28602971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute kidney injury and hepatorenal syndrome in cirrhosis.
    Egerod Israelsen M; Gluud LL; Krag A
    J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatorenal syndrome: Current concepts and future perspectives.
    Jung CY; Chang JW
    Clin Mol Hepatol; 2023 Oct; 29(4):891-908. PubMed ID: 37050843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hepatorenal syndrome.
    Kiser TH; Maclaren R; Fish DN
    Pharmacotherapy; 2009 Oct; 29(10):1196-211. PubMed ID: 19792993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].
    Lenz K; Buder R; Lohr G; Piringer P; Voglmayr M
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):440-6. PubMed ID: 27241778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review.
    Flamm SL; Wong F; Ahn J; Kamath PS
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2707-2716. PubMed ID: 36075500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatorenal syndrome].
    Huschak G; Kaisers UX; Laudi S
    Anaesthesist; 2013 Jul; 62(7):571-82. PubMed ID: 23846211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
    Boyer TD; Sanyal AJ; Wong F; Frederick RT; Lake JR; O'Leary JG; Ganger D; Jamil K; Pappas SC;
    Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatorenal Disorders.
    Al-Khafaji A; Nadim MK; Kellum JA
    Chest; 2015 Aug; 148(2):550-558. PubMed ID: 25811649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascites and Hepatorenal Syndrome.
    Adebayo D; Neong SF; Wong F
    Clin Liver Dis; 2019 Nov; 23(4):659-682. PubMed ID: 31563217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatorenal syndrome.
    Bataller R; Ginès P; Arroyo V; Rodés J
    Clin Liver Dis; 2000 May; 4(2):487-507. PubMed ID: 11232202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document.
    Angeli P; Garcia-Tsao G; Nadim MK; Parikh CR
    J Hepatol; 2019 Oct; 71(4):811-822. PubMed ID: 31302175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatorenal syndrome.
    Guevara M; Rodés J
    Int J Biochem Cell Biol; 2005 Jan; 37(1):22-6. PubMed ID: 15381144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
    Ripoll C; Platzer S; Franken P; Aschenbach R; Wienke A; Schuhmacher U; Teichgräber U; Stallmach A; Steighardt J; Zipprich A;
    Trials; 2023 Apr; 24(1):258. PubMed ID: 37020315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of Hepatorenal Syndrome.
    Velez JCQ; Latt N; Rodby RA
    Adv Kidney Dis Health; 2024 Mar; 31(2):87-99. PubMed ID: 38649221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatorenal syndrome: focus].
    Gueutin V; Meftah A; Desbuissons G; Debchi L; Langlois AL; Shehwaro N; Izzedine H
    Nephrol Ther; 2013 Dec; 9(7):471-80. PubMed ID: 23850001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatorenal syndrome].
    Mijac D; Kezić A; Stojimirović B
    Srp Arh Celok Lek; 2007; 135(1-2):98-104. PubMed ID: 17503577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.